Form 8-K - Current report:
SEC Accession No. 0000950170-24-117576
Filing Date
2024-10-28
Accepted
2024-10-28 08:10:38
Documents
12
Period of Report
2024-10-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-20241028.htm   iXBRL 8-K 51348
2 GRAPHIC img216206629_0.jpg GRAPHIC 55684
  Complete submission text file 0000950170-24-117576.txt   299249

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20241028.xsd EX-101.SCH 23903
14 EXTRACTED XBRL INSTANCE DOCUMENT evok-20241028_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 241398463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)